12:00 AM
Mar 23, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Durezol difluprednate regulatory update

FDA accepted for filing an sNDA from Sirion for Durezol difluprednate to treat endogenous anterior uveitis. The PDUFA...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >